GLP-1 Agonists in Dermatology

In this episode, we explore the growing intersection between metabolic therapy and dermatology.

GLP-1 receptor agonists have transformed the treatment of type 2 diabetes and obesity, but their implications may extend far beyond metabolic disease. We discuss emerging evidence on inflammation and immunity, inflammatory skin disorders, skin-related adverse effects, wound healing, aesthetic procedures, and future developments including dual and triple agonists.

Featuring Dr. Samira Baharlou, this conversation examines a rapidly evolving area with important implications for clinical practice and research.

Enjoy the episode.